Clinical Trials Logo
  1. Home
  2. Epilepsy Intractable
  3. NCT04399954

Evaluation of Ketoflo — Ketoflo  

Ketogenic Dieting Clinical Trial

Official title:
A Study to Evaluate the Acceptability of Ketoflo, a Food for Special Medical Purposes (FSMP) for Use in the Dietary Management of Epilepsy or Neurometabolic Conditions Requiring a Ketogenic Diet (KD)

Clinical Trial Summary

For 28 days, 30 participants aged 3 to 18 years of age (inclusive) with a condition requiring a ketogenic diet will incorporate Ketoflo into their usual dietary regime. Ketoflo is a nutritionally complete Food For Special Medical Purposes and is suitable for administration by both tube feeding and use as a sip feed. Data on gastrointestinal tolerance, participants adherence to recommended intakes and their thoughts on the product's palatability will be self-reported in Daily Study Diaries.

Clinical Trial Description

This is a 28-day prospective study to evaluate the acceptability of Ketoflo, in terms of GI tolerance, adherence to recommended intakes and palatability. The product's nutritional suitability for use in a ketogenic diet will also be evaluated by recording ketone levels and seizure frequency measured as part of usual clinical care. Ketoflo is nutritionally complete liquid feed for use in the dietary management of epilepsy or other neurometabolic conditions requiring a ketogenic diet. It is designed to be nutritionally complete from 3-18 years and can be used as a supplementary feed thereafter. Ketoflo has been designed in liaison with Key Opinion Leaders and will offer an additional choice of prescribe-able feeds for use in the ketogenic diet. The study will involve 30 participants, aged between three and eighteen years of age (inclusive), who are already established on a ketogenic diet for at least three months before the study begins. Participants will self-report data in Daily Study Diaries over the course of the study. Data will also be collected by the Investigators in Baseline CRFs and End of Study CRFs for all participants. Any data collected for the study will be anonymised before being relayed to the sponsor. The data generated by the trial will be used to support a submission by Vitaflo (International) Ltd. to the Advisory Committee on Borderline Substances (ACBS) for Ketoflo to become reimbursable on prescription in the UK. The data will also be used in a submission to the General Medical Services in the Republic of Ireland. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04399954
Study type Interventional
Source Vitaflo International, Ltd
Contact
Status Completed
Phase N/A
Start date February 24, 2020
Completion date June 30, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Completed NCT03141008 - Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Terminated NCT03790436 - Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet N/A
Not yet recruiting NCT06013397 - Effectiveness of Ketogenic Diet in MELAS Syndrome N/A
Recruiting NCT05689580 - The Influence of Ketogenic Diet on Lupus Nephritis Patients' Immunity N/A
Recruiting NCT04492228 - Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome N/A
Completed NCT05603689 - Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude N/A
Completed NCT04744558 - Low Carbohydrate High Fat Ketogenic vs. Non-ketogenic Diet N/A
Completed NCT04108819 - Ketogenic Diet for Obesity Hypoventilation Syndrome N/A
Completed NCT04130724 - Characterization of a Portable Solid-State Breath Acetone Testing Device for Real-Time Ketosis Status
Enrolling by invitation NCT05049954 - Weight Loss for a Healthier You Programme N/A
Recruiting NCT03564002 - Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
Recruiting NCT05591508 - Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus N/A
Completed NCT04112862 - Sodium Lactate Infusion in GLUT1DS Patients Early Phase 1
Recruiting NCT03991897 - Ketogenic Diet: a Novel Metabolic Strategy to Treat Lymphedema Patients? N/A
Withdrawn NCT03202108 - Evaluation of Krio in Children and Adults With Epilepsy N/A
Completed NCT05012748 - The Effects of Ketogenic Diet on the Heart and Brain N/A
Completed NCT03982602 - Ketogenic Diet for Traumatic Brain Injury Early Phase 1
Recruiting NCT06022796 - Weight Loss Interventions for Obesity N/A
Completed NCT05219006 - Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures N/A